Correction to: T cell leukemia control via Ras-Raf pathway inhibition with peptides.

Marin, G H; Rebollo, A; Bruzzoni-Giovanelli, H; Schinella, G; Piazzon, I; Duarte, A; Errecalde, J

Marin, G H; Rebollo, A; Bruzzoni-Giovanelli, H; Schinella, G; Piazzon, I; Duarte, A; Errecalde, J.

Afiliación

Marin GH; National University of La Plata - Pharmacology Department-CONICET.
Rebollo A; CIMI, Inserm/UPMC/CNRS- Université Pierre et Marie Curie, Paris 6, France; Centre d'Immunologie et des Maladies Infectieuses.
Bruzzoni-Giovanelli H; Université Paris 7- Hôpital Saint Louis, Pharmacology - Centre d'Investigations Cliniques.
Schinella G; National University of La Plata - Pharmacology Department-CONICET.
Piazzon I; National Academy of Medicine, Argentina, Experimental Immunology Laboratory.
Duarte A; National Academy of Medicine, Argentina, Experimental Immunology Laboratory.
Errecalde J; National University of La Plata - Pharmacology Department-CONICET.

J Med Life ; 11(1): 83, 2018.

Article en En | MEDLINE | ID: mdl-29697701

RESUMEN

[This corrects the article on p. 172 in vol. 10, PMID: 29075346.].

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Med Life Asunto de la revista: MEDICINA Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google